IN2015DN01524A - - Google Patents
Info
- Publication number
- IN2015DN01524A IN2015DN01524A IN1524DEN2015A IN2015DN01524A IN 2015DN01524 A IN2015DN01524 A IN 2015DN01524A IN 1524DEN2015 A IN1524DEN2015 A IN 1524DEN2015A IN 2015DN01524 A IN2015DN01524 A IN 2015DN01524A
- Authority
- IN
- India
- Prior art keywords
- compounds
- disorders
- humans
- animals
- present
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- -1 retinoid compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Birds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/594,177 US8475775B1 (en) | 2012-08-24 | 2012-08-24 | Retinoids and use thereof |
| PCT/US2013/048891 WO2014031242A1 (en) | 2012-08-24 | 2013-07-01 | Retinoids and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01524A true IN2015DN01524A (pl) | 2015-07-03 |
Family
ID=48671166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1524DEN2015 IN2015DN01524A (pl) | 2012-08-24 | 2013-07-01 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8475775B1 (pl) |
| EP (1) | EP2887928B1 (pl) |
| JP (1) | JP6382817B2 (pl) |
| KR (1) | KR20150045450A (pl) |
| CN (1) | CN104540502A (pl) |
| AU (1) | AU2013306281B2 (pl) |
| BR (1) | BR112015003561A8 (pl) |
| CA (1) | CA2882330A1 (pl) |
| CL (1) | CL2015000434A1 (pl) |
| CO (1) | CO7350653A2 (pl) |
| ES (1) | ES2670499T3 (pl) |
| HU (1) | HUE037075T2 (pl) |
| IL (1) | IL236991B (pl) |
| IN (1) | IN2015DN01524A (pl) |
| MX (1) | MX366050B (pl) |
| NZ (1) | NZ704496A (pl) |
| RU (1) | RU2687285C2 (pl) |
| WO (1) | WO2014031242A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10328040B2 (en) | 2014-01-17 | 2019-06-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic methods |
| US9908856B2 (en) | 2014-02-26 | 2018-03-06 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10112917B2 (en) | 2015-03-03 | 2018-10-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
| US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
| US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US11696897B2 (en) * | 2019-10-02 | 2023-07-11 | Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts, Universitatsmedizin | Method for the treatment of diseases associated with sulfatase deficiencies |
| JP2022056688A (ja) * | 2020-09-30 | 2022-04-11 | キオクシア株式会社 | 半導体装置 |
| CN113207799B (zh) * | 2021-03-19 | 2022-03-15 | 中山大学 | 一种二型糖尿病小鼠快速心衰模型的构建方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5094783A (en) | 1990-06-29 | 1992-03-10 | Uab Research Foundation | Retinoid compounds |
| US6172112B1 (en) | 1998-04-06 | 2001-01-09 | Uab Research Foundation | Retinoids and use thereof |
| JP4699347B2 (ja) * | 2003-01-17 | 2011-06-08 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | 改質されたレチノイド化合物及びその使用 |
| BRPI0514600A (pt) | 2004-08-24 | 2008-06-17 | Uab Research Foundation | métodos para a fabricação de um composto, para a purificação de um composto, para o tratamento de um indivìduo tendo uma condição neoplástica, tendo carcinoma de célula escamosa, e tendo carcinoma de célula basal, para a redução ou prevenção da ocorrência de uma condição neoplástica em um indivìduo, e para a redução de triglicerìdeos no soro em um indivìduo, composto, e, composição farmacêutica |
| CA2787339A1 (en) * | 2009-01-20 | 2011-08-12 | Signum Biosciences, Inc. | Anti-inflammatory complexes |
| WO2011141822A2 (en) * | 2010-05-11 | 2011-11-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors |
-
2012
- 2012-08-24 US US13/594,177 patent/US8475775B1/en active Active
-
2013
- 2013-07-01 HU HUE13831096A patent/HUE037075T2/hu unknown
- 2013-07-01 IN IN1524DEN2015 patent/IN2015DN01524A/en unknown
- 2013-07-01 WO PCT/US2013/048891 patent/WO2014031242A1/en active Application Filing
- 2013-07-01 AU AU2013306281A patent/AU2013306281B2/en not_active Ceased
- 2013-07-01 JP JP2015528466A patent/JP6382817B2/ja not_active Expired - Fee Related
- 2013-07-01 NZ NZ704496A patent/NZ704496A/en not_active IP Right Cessation
- 2013-07-01 EP EP13831096.6A patent/EP2887928B1/en not_active Not-in-force
- 2013-07-01 US US13/932,294 patent/US20140057982A1/en not_active Abandoned
- 2013-07-01 MX MX2015002340A patent/MX366050B/es active IP Right Grant
- 2013-07-01 ES ES13831096.6T patent/ES2670499T3/es active Active
- 2013-07-01 RU RU2015103469A patent/RU2687285C2/ru not_active IP Right Cessation
- 2013-07-01 CN CN201380042696.8A patent/CN104540502A/zh active Pending
- 2013-07-01 BR BR112015003561A patent/BR112015003561A8/pt not_active IP Right Cessation
- 2013-07-01 CA CA2882330A patent/CA2882330A1/en not_active Abandoned
- 2013-07-01 KR KR20157005128A patent/KR20150045450A/ko active IP Right Grant
- 2013-07-01 US US14/422,645 patent/US20150202174A1/en not_active Abandoned
-
2015
- 2015-01-29 IL IL236991A patent/IL236991B/en active IP Right Grant
- 2015-02-23 CL CL2015000434A patent/CL2015000434A1/es unknown
- 2015-02-25 CO CO15041667A patent/CO7350653A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013306281A1 (en) | 2015-02-26 |
| AU2013306281B2 (en) | 2018-08-02 |
| RU2687285C2 (ru) | 2019-05-13 |
| HUE037075T2 (hu) | 2018-08-28 |
| KR20150045450A (ko) | 2015-04-28 |
| NZ704496A (en) | 2017-01-27 |
| CO7350653A2 (es) | 2015-08-10 |
| EP2887928B1 (en) | 2018-02-21 |
| RU2015103469A (ru) | 2016-10-20 |
| CA2882330A1 (en) | 2014-02-27 |
| BR112015003561A8 (pt) | 2018-01-23 |
| JP6382817B2 (ja) | 2018-08-29 |
| WO2014031242A1 (en) | 2014-02-27 |
| MX366050B (es) | 2019-06-26 |
| CN104540502A (zh) | 2015-04-22 |
| JP2015526464A (ja) | 2015-09-10 |
| EP2887928A1 (en) | 2015-07-01 |
| BR112015003561A2 (pt) | 2017-07-04 |
| US20140057982A1 (en) | 2014-02-27 |
| ES2670499T3 (es) | 2018-05-30 |
| CL2015000434A1 (es) | 2015-07-17 |
| MX2015002340A (es) | 2015-08-05 |
| IL236991B (en) | 2019-03-31 |
| US20150202174A1 (en) | 2015-07-23 |
| US8475775B1 (en) | 2013-07-02 |
| EP2887928A4 (en) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01524A (pl) | ||
| PH12015500525A1 (en) | Formulations of enzalutamide | |
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| MX2016003129A (es) | Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano. | |
| IL283432A (en) | Preparations, methods and systems for the treatment of skin disorders | |
| JO3343B1 (ar) | أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها | |
| RS53893B1 (en) | USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT | |
| MX2015012428A (es) | Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios. | |
| UY34616A (es) | Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias. | |
| MX360710B (es) | Antagonistas de il17c para el tratamiento de trastornos inflamatorios. | |
| IN2014DN11078A (pl) | ||
| MX2015006337A (es) | Metodos y composiciones para tratar enfermedades neurodegenerativas. | |
| EP3003299B8 (en) | Novel n-3 immunoresolvents: structures and actions | |
| HK1221166A1 (zh) | 炎症性病症的治療 | |
| MX363385B (es) | Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias. | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| EP3033080A4 (en) | Methods and compositions for increasing the effectiveness of antiviral agents | |
| AU2014353885A8 (en) | Prevention and treatment of toxicosis | |
| GB201314015D0 (en) | Novel compound useful for the treatment of degenerative and inflammatory diseases | |
| GB201315079D0 (en) | Novel compounds useful for the treatment of degenerative and inflammatory diseases | |
| UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
| UA86158U (en) | Antibacterial agent | |
| UA27047S (uk) | Редуктор до форматора-вулканізатора 75'' та 88'' | |
| UY4265Q (es) | Automóvil | |
| UA78375U (ru) | Применение сорбента "силикс" как антисептического и вяжущего средства |